Unified Development Platforms

The use cases, benefits, and strategies defining the future of life sciences technology.

Let's Connect

By clicking ‘Submit’ button, you are agreeing to opt-in to communications from ArisGlobal and use of the above information for ArisGlobal products, news & updates.

Note: You can unsubscribe to email communication from ArisGlobal any time.

As a value creation opportunity, the most significant digital transformation potential within life sciences lies within the R&D function. Here, technological modernization can enable organizations to bring their products to market far more rapidly and safely, and at a lower cost. The potential impact of a successfully executed digital transformation strategy on drug development is significant. But what does digital transformation within drug development actually look like?

This whitepaper explores digital transformation in the context of life sciences R&D, focusing specifically on the concept of a unified drug development technology platform. There are different philosophies underlying the strategies of various platform providers, and we will detail our view on the advantages and disadvantages of each approach.

Key Highlights:

  • Use cases of unifying functions across the R&D Lifecycle
  • Key benefits of a platform approach
  • The current state of unified platforms

Read the Whitepaper Today!